Unlocking The Potential of S6 Kinase as A Drug Target and Biomarker

Target Name: Ribosomal protein S6 kinase (RSK)

NCBI ID: P40580

Ribosomal protein S6 kinase (RSK)

Other Name(s): p70 Ribosomal S6 kinase | RSK | Rsk | S6K

Unlocking The Potential of S6 Kinase as A Drug Target and Biomarker

Ribosomal protein S6 kinase (RSK) is a protein that plays a crucial role in the regulation of gene expression and cell signaling. It is a non-species specific subunit of the ribosomal protein S6 complex and is composed of two distinct isoforms, p70 and p72 . While both isoforms share similar structural features, they exhibit distinct functions due to their unique localization and stability. p70 Ribosomal S6 kinase is a protein that has been identified as a potential drug target and may serve as a biomarker for various diseases.

The ribosomal protein S6 complex is a large protein complex that plays a significant role in the regulation of gene expression. It is composed of various subunits, including S6 protein, S6A protein and S6B protein. These subunits are involved in the different stages of gene expression, such as initiation, elongation, and termination. S6 kinase is a subunit that is specifically involved in the regulation of gene expression and cell signaling.

S6 kinase is composed of two distinct isoforms, p70 and p72. p70 Ribosomal S6 kinase is a 21-kDa protein that is predominantly localized to the cytoplasm. It has been shown to play a role in the regulation of cell signaling, cell adhesion, and cell cycle progression. In addition, p70 has been shown to interact with various protein substrates, including histone modifications and non-histone modifications.

On the other hand, p72 Ribosomal S6 kinase is a 66-kDa protein that is predominantly localized to the nucleus. It is known to play a role in the regulation of gene expression, DNA replication, and cell signaling. p72 has been shown to interact with various protein substrates, including histone modifications and non-histone modifications.

The p70 subunit of S6 kinase has been shown to have various functions, including regulating the stability of S6 protein, S6A protein and S6B protein. It has been shown to play a role in the regulation of cell signaling, cell adhesion, and cell cycle progression. In addition, p70 has been shown to interact with various protein substrates, including histone modifications and non-histone modifications.

In addition to its functions in gene expression and cell signaling, p70 has also been shown to have potential as a drug target. Several studies have shown that inhibition of S6 kinase can lead to therapeutic effects in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. In addition, p70 has also been shown to be a potential biomarker for various diseases, including cancer.

The p70 subunit of S6 kinase has been shown to have various functions, including regulating the stability of S6 protein, S6A protein and S6B protein, etc. It has been shown to play a role in the regulation of cell signaling, cell adhesion, and cell cycle progression. In addition, p70 has been shown to interact with various protein substrates, including histone modifications and non-histone modifications.

In addition to its functions in gene expression and cell signaling, p70 has also been shown to have potential as a drug target. Several studies have shown that inhibition of S6 kinase can lead to therapeutic effects in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. In addition, p70 has also been shown to be a potential biomarker for various diseases, including cancer.

Overall, p70 Ribosomal S6 kinase is a protein that has been identified as a potential drug target and may serve as a biomarker for various diseases. Further research is needed to fully understand the functions of p70 and its potential as a drug

Protein Name: Ribosomal Protein S6 Kinase (RSK) (nonspecified Subtype)

The "Ribosomal protein S6 kinase (RSK) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Ribosomal protein S6 kinase (RSK) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets